Free Trial

Prestige Consumer Healthcare Q2 2025 Earnings Report

Prestige Consumer Healthcare logo
$84.70 -0.30 (-0.35%)
(As of 12/3/2024 ET)

Prestige Consumer Healthcare EPS Results

Actual EPS
$1.09
Consensus EPS
$1.09
Beat/Miss
Met Expectations
One Year Ago EPS
$1.07

Prestige Consumer Healthcare Revenue Results

Actual Revenue
$283.79 million
Expected Revenue
$282.09 million
Beat/Miss
Beat by +$1.70 million
YoY Revenue Growth
-0.90%

Prestige Consumer Healthcare Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Amazon coin set to soar 25X – starting December 16th? (Ad)

This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team of crypto experts has identified it as the most promising crypto of 2024. You can see all of the details surrounding the #1 Crypto of 2024

>3-Cent Amazon Coin<

Prestige Consumer Healthcare Earnings Headlines

What is Zacks Research's Estimate for PBH Q4 Earnings?
The Crypto Secret Wall Street Doesn’t Want You to Know
The Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech giants are quietly integrating it. Venture capitalists are scrambling to invest.
See More Prestige Consumer Healthcare Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Prestige Consumer Healthcare? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Prestige Consumer Healthcare and other key companies, straight to your email.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

View Prestige Consumer Healthcare Profile

More Earnings Resources from MarketBeat